跳至主要内容
临床试验/NCT06988865
NCT06988865已完成不适用

Benign Migratory Glossitis Associated With Antiangiogenic Drugs Used in Cancer Treatment

Instituto do Cancer do Estado de São Paulo1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2017年7月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
8
试验地点
1
主要终点
Benign migratory glossitis

研究概览

简要总结

Oral clinical descriptions related to adverse events in patients treated with those elective multi-targeted receptor tyrosine kinase inhibitors and a recombinant humanised monoclonal antibody

详细描述

Electronical medical and dental records, high-resolution digital photograph were reviewed. Demographic data, medical background, clinical and laboratory information were recorded for each individual case.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •patient's charts which underwent antiangiogenic targeted drugs

排除标准

  • •chemoterapy without angiogenesis inhibitors

结局指标

主要结局

Benign migratory glossitis

时间窗: From enrollment to the end of study at 7 years

erythematous erosions, with loss of filiform papillae, surrounded by white circinate rims on the dorsal tongue

次要结局

  • Adverse events(From enrollment to the end of study at 7 years)

研究者

发起方
Instituto do Cancer do Estado de São Paulo
申办方类型
Other
责任方
Principal Investigator
主要研究者

MAURICIO NEVES GOMES

Assistant, Dental Oncology Service, Instituto do Câncer do Estado de São Paulo (ICESP-FMUSP)

Instituto do Cancer do Estado de São Paulo

研究点 (1)

Loading locations...

相似试验

Benign Migratory Glossitis Associated With... | 临床试验